Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oxaliplatin 100mg/20ml solution for infusion vials
0801050ALAAABAB
|
Oxaliplatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Oxaliplatin 150mg powder for solution for infusion vials
0801050ALAAAFAF
|
Oxaliplatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Oxaliplatin 200mg/40ml solution for infusion vials
0801050ALAAAEAE
|
Oxaliplatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Oxaliplatin 50mg powder for solution for infusion vials
0801050ALAAACAC
|
Oxaliplatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Oxaliplatin 50mg/10ml solution for infusion vials
0801050ALAAAAAA
|
Oxaliplatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Oyavas 100mg/4ml concentrate for solution for infusion vials
0801050APBFABAA
|
Oyavas | Bevacizumab | Malignant Disease and Immunosuppression | No data available |
|
Oyavas 400mg/16ml concentrate for inf vials
0801050APBFAAAB
|
Oyavas | Bevacizumab | Malignant Disease and Immunosuppression | No data available |
|
Ozanimod 230microgram caps and Ozanimod 460microgram caps
0802040BFAAABAB
|
Ozanimod | Ozanimod | Malignant Disease and Immunosuppression | No data available |
|
Ozanimod 920microgram capsules
0802040BFAAAAAA
|
Ozanimod | Ozanimod | Malignant Disease and Immunosuppression | No data available |
|
Paclitaxel 100mg/16.7ml solution for infusion vials
0801050V0AAABAB
|
Paclitaxel | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paclitaxel 150mg/25ml solution for infusion vials
0801050V0AAACAC
|
Paclitaxel | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paclitaxel 300mg/50ml solution for infusion vials
0801050V0AAADAD
|
Paclitaxel | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paclitaxel 30mg/5ml solution for infusion vials
0801050V0AAAAAA
|
Paclitaxel | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Palbociclib 100mg capsules
0801050CBAAABAB
|
Palbociclib | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Palbociclib 100mg tablets
0801050CBAAADAD
|
Palbociclib | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Palbociclib 125mg capsules
0801050CBAAACAC
|
Palbociclib | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Palbociclib 125mg tablets
0801050CBAAAEAE
|
Palbociclib | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Palbociclib 75mg capsules
0801050CBAAAAAA
|
Palbociclib | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Palbociclib 75mg tablets
0801050CBAAAFAF
|
Palbociclib | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Palifermin 6.25mg powder for solution for injection vials
0801000W0AAAAAA
|
Palifermin | Palifermin | Malignant Disease and Immunosuppression | No data available |
|
Panitumumab 100mg/5ml solution for infusion vials
0801050ARAAAAAA
|
Panitumumab | Panitumumab | Malignant Disease and Immunosuppression | No data available |
|
Panitumumab 400mg/20ml solution for infusion vials
0801050ARAAABAB
|
Panitumumab | Panitumumab | Malignant Disease and Immunosuppression | No data available |
|
Panobinostat 10mg capsules
0801050BWAAABAB
|
Panobinostat | Panobinostat | Malignant Disease and Immunosuppression | No data available |
|
Panobinostat 15mg capsules
0801050BWAAACAC
|
Panobinostat | Panobinostat | Malignant Disease and Immunosuppression | No data available |
|
Panobinostat 20mg capsules
0801050BWAAAAAA
|
Panobinostat | Panobinostat | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.